trending Market Intelligence /marketintelligence/en/news-insights/trending/mFDEGUvOqI6s1df9zz2fHg2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Senate health leaders reach bipartisan short-term deal to continue ACA subsidies

Infrastructure Issues: Tools to Dig Deep on Potential Risks

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

Part Two IFRS 9 Blog Series: The Need to Upgrade Analytical Tools

Senate health leaders reach bipartisan short-term deal to continue ACA subsidies

Sens. Lamar Alexander, R-Tenn., chairman of the Senate Health, Education, Labor and Pensions Committee, and Patty Murray, D-Wash., the panel's ranking member, said Oct. 17 they reached an agreement on a bipartisan deal to fund for two years the subsidies provided under the Affordable Care Act, or ACA, that help low-income Americans cover the costs of their prescription drugs and doctor visits.

President Donald Trump, who cut off the so-called cost-sharing reduction, or CSR, payments Oct. 12, told reporters he was aware of the deal and said he backed the plan.

The CSRs will be funded in exchange for allowing states to have greater flexibility in using waivers to approve insurance plans with comparable affordability as those offered under the ACA requirements.

The lawmakers, however, were still working out final details and planned to brief their colleagues later in the day.

It remains unclear whether the House is on board with the agreement.

Trump is facing at least one multiparty lawsuit from attorneys general in 18 states and the District of Columbia for halting the CSR payments.